BenevolentAI Competitors and Similar CompaniesClear all

BenevolentAI's competitors and similar companies include LabGenius and Recursion Pharmaceuticals.
BenevolentAI
BenevolentAI
BenevolentAI is a company that develops artificial intelligence and machine learning technologies for drug discovery and life sciences.
LabGenius
LabGenius
LabGenius is a company that provides machine learning (ML) driven antibody discovery solutions.
Recursion Pharmaceuticals
Recursion Pharmaceuticals
Recursion Pharmaceuticals is a company that offers drug discovery and treatments using artificial intelligence, automation, bioinformatics, and experimental biology.
Founding Date
Founding Date
2013
Founding Date
2012
Founding Date
2013
Type
Type
Private
Type
Private
Type
Public
Tags
Locations
Locations
London, GB HQ
Babraham, GB
Locations
London, GB HQ
London, GB
Locations
Salt Lake City, US HQ
Employees
Employees
180
Employees
681% increase
Employees
216
Valuation ($)
Valuation ($)
1 b
Valuation ($)
N/A
Valuation ($)
2 b

Financial

Revenue (est.)
Revenue (est.)
€7.3m (FY, 2023)
Revenue (est.)
N/A
Revenue (est.)
$74.7m (FY, 2025)
Cost of goods
Cost of goods
N/A
Cost of goods
£5.5m (FY, 2023)
Cost of goods
$71m (FY, 2025)
Gross profit
Gross profit
€7.8m (FY, 2023)
Gross profit
(£5.5m) (FY, 2023)
Gross profit
$3.7m (FY, 2025)
Net income
Net income
(€63.3m) (FY, 2023)
Net income
(£6.8m) (FY, 2023)
Net income
($644.8m) (FY, 2025)

Funding

Latest funding round
Latest funding round
$ 90m (over 6 years ago)
Latest funding round
$ 15m (over 5 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 305m
Total funding raised
$ 28.7m
Total funding raised
$ 437.1m
For sources of this data, please see the company profile

View Company Profiles

LabGenius
HQ
London, GB
Employees
68↑ 1% increase

LabGenius is a company that provides machine learning (ML) driven antibody discovery solutions.

View company
Recursion Pharmaceuticals
HQ
Salt Lake City, US
Employees
216

Recursion Pharmaceuticals is a company that offers drug discovery and treatments using artificial intelligence, automation, bioinformatics, and experimental biology.

View company